The report "Dental Bone Graft Substitutes Market by Type (Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Region - Global Forecast to 2031" is projected to grow from USD 1.40 billion in 2026 and to reach USD 2.04 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
Browse 250 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "Dental Bone Graft Substitutes Market by Type (Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/dental-bone-graft-substitutes-market-159678690.html
The dental bone graft substitutes market is primarily driven by the rising incidence of dental diseases, including tooth loss, periodontal disease, and maxillofacial issues. This trend has created a growing demand for dental bone regeneration products. In recent years, dental implants have significantly contributed to the expansion of the bone graft substitutes market, driven by their growing applications in dentistry.
Bone graft substitutes, including xenografts, allografts, and synthetic materials, have undergone remarkable technological advancements for dental reconstruction, improving precision and reliability during implantation. Additionally, heightened awareness among patients and dental care professionals regarding the importance of dental health has further fueled the growth of the bone graft substitutes market. The increase in dental clinics across various countries has also played a crucial role in the market's expansion in recent years.
The osteoconduction segment accounted for the largest share of the dental bone graft substitutes market, by mechanism, in 2024.
The osteoconduction segment plays a significant role in the dental bone graft substitutes market, as it is essential for effective osseous regeneration. This process is critical for providing a supporting structure that allows bone cells to attach and grow. Therefore, these materials are particularly useful in various dental procedures, including dental implants, sinus lifts, and the treatment of periodontal diseases and defects. Commonly used bone grafting agents, such as xenografts, allografts, and synthetic materials, are primarily osteoconductive. Consequently, their sales have a substantial impact on the market for dental and bone graft substitutes. These materials are often preferred clinically for their predictable outcomes and lower biological risks compared to other osseous linkages, such as osteogenesis and osteoinduction.
The hospitals segment accounted for the largest share of the dental bone graft substitutes market, by end user, in 2024.
Among the various end-user segments of the dental bone graft substitutes market, hospitals are the most dominant. This is primarily due to their robust clinical infrastructure, high patient turnover, and capability to perform a wide range of complex dental and oral procedures. Hospitals frequently handle cases that require bone grafts, such as dental implant surgeries, periodontal treatments, and reconstructive interventions that utilize advanced graft materials. Additionally, hospitals typically have specialized units for dental and maxillofacial surgeries staffed with experienced surgeons and well-trained personnel. This enables them to use bone graft substitutes more effectively than smaller clinics or individual practices. The significant demand for dental bone graft substitutes in hospitals stems from their status as leading performers of these procedures, their technical expertise, and their access to advanced surgical instruments.
Key Market Players
The key players in the dental bone graft substitutes market are Dentsply Sirona (US), Envista (US), Johnson & Johnson (US), Institut Straumann AG (Switzerland), Medtronic (Ireland), Zimvie Inc. (US), Henry Schein Inc. (US), RTI Surgical (US), and LifeNet Health (US), among other players.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/